SME in 6 Cards/Precision Engineering/Apsis Aerocom Ltd
SME in 6 Cards

This Bangalore micro-cap makes precision parts for global aerospace & defence OEMs

₹20 Cr revenue, 50% EBITDA margins, 92% RoE — filing for an SME IPO on NSE EMERGE.

K

KnowYourSME Research

May 2026 · 6 min read

₹20.5 Cr
Revenue FY25
₹6.6 Cr
PAT FY25
49.8%
EBITDA Margin
NSE EMERGE
IPO Platform

The business

Apsis Aerocom provides Build-to-Print and Build-to-Specification precision CNC machining services for Tier-1 global OEMs across defence (45%), aerospace (30%), and healthcare (22%). Operating from a compact 8,462 sq ft facility in Peenya Industrial Area, Bangalore with 16 CNC machines including 5-axis MAKINO, MAZAK, and OKUMA. AS9100D + ISO 9001:2015 certified. 99.99% aggregate accuracy over last 3 fiscal years.

Precision EngineeringAerospace & Defence

Why this business matters

Aerospace & Defence boom — India's defence budget ₹6.2L Cr, Make in India & PLI schemes driving indigenous precision manufacturing demand

Healthcare precision parts — growing demand for surgical instruments, blood testing scanners, and diagnostic device components

Global supply chain shift — post-COVID diversification away from China benefits Indian precision manufacturers with AS9100D certification

The moat

EBITDA
49.8%
EBITDA margin FY25 — exceptional for manufacturing
RoE
91.6%
Return on Equity FY25 — capital efficient
Revenue
₹20.5Cr
97% CAGR over 2 years (FY23→FY25)
PAT
₹6.6Cr
PAT margin 32.4% — very high profitability

Reality check

Top 1 customer = 52% revenue — extreme customer concentration risk. Top 5 = 94.6%

Tiny scale — only ₹20 Cr revenue, 8,462 sq ft factory. Capacity constraints at scale

Promoter holding 99.72% — virtually no public float pre-IPO. All 3 promoters are NTTF-trained machinists aged 36-49

Cash position dropped — from ₹2.08 Cr to ₹0.07 Cr as capital deployed into PPE and inventory build-up

🚪

Exit Trigger

Exit if customer concentration worsens (top 1 > 60%), or if IPO funds aren't deployed into capacity expansion within 12 months

The verdict

Strong micro-cap play — exceptional margins and niche positioning in precision aerospace/defence manufacturing. But scale is tiny and customer concentration is a real risk.

Watch For

IPO subscription numbers, post-listing capacity expansion plans, new customer additions beyond top 5, and FY26 Q1 revenue trajectory.

Want the full story?

Read our comprehensive 7-chapter Deep Dive with financials, management analysis, IPO tracker, and more.

Read Full Deep Dive

A micro-cap precision engineering play entering aerospace & defence — hidden gem or too small to matter?

Share your view in the comments below

Disclaimer: For educational purposes only. Not SEBI-registered. Author may hold positions in stocks discussed. Not a buy/sell/hold recommendation. Do your own due diligence.

More SME in 6 Cards